About us

Diaorigin Biotechnology

Professional CDMO and CRO services

Presentation of the laboratory

In September 2019 Diaorigin created its research laboratory in Shanghai by the founder of Larix Bioscience, Dr. Bo YU, holder of the SwiMR patent, a high performance technology to produce recombinant antibodies for the ivd industry.


In December 2020, Diaorigin headquarted in Paris, headed by Dr. Yongjin WANG, a former researcher at the Institut Pasteur, who is in charge of marketing and development.

. 

Diaorigin laboratory is committed to providing IVD companies and research institutes with the design, development and preparation of antigen and antibody raw materials. The company has innovative platforms and technologies for molecular cloning, cell line development, protein purification and mass production of antibodies.

Our founders

Bo YU

Ph.D
 Ph.D at California Institute of Technology;
Founder of Larix Bioscience laboratory;
Holder of SwiMR and DAKO technology; 
20 years of experience in antibody drug research.

Mingyao LIU

Ph.D / professor
Ph.D at University of Maryland (1992);
Professor at Texas A&M University; 
Head of Faculty of Science ECNU; 
Director at Shanghai Key Laboratory of Regulatory Biology.

Yongjin Wang

Ph.D
Ph.D at Henri Poincaré University; 
8 years as a postdoctoral researcher at the Institut Pasteur Shanghai/Paris; 
7 years of experience in the pharmaceutical industry; 
CEO of Diaorigin Biotechnology Paris.
Share by: